or Try an Advanced Search...

    Technical Analysis for CVKD - Cadrenal Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 0.46 -1.15% -0.01
    CVKD closed down 1.15 percent on Monday, July 1, 2024, on 66 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Down
    Historical CVKD trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Bollinger Band Squeeze Range Contraction -1.15%
    NR7 Range Contraction -1.15%
    NR7-2 Range Contraction -1.15%
    Narrow Range Bar Range Contraction -1.15%
    Inside Day Range Contraction -1.15%
    Gapped Up Strength -1.15%
    Fell Below 20 DMA Bearish 2.02%
    MACD Bearish Signal Line Cross Bearish 2.02%
    Older End-of-Day Signals for CVKD ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 9 hours ago
    20 DMA Resistance about 9 hours ago
    10 DMA Resistance about 9 hours ago
    Down 2 % about 9 hours ago
    Down 1% about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CVKD Chart by TradingView
    Basic chart:

    Profile

    Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Hematology End Stage Renal Disease Cardiac Arrhythmia Atrial Fibrillation Venous Thrombosis

    Is CVKD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 12 Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
    Jun 11 Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024
    Jun 11 Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
    Jun 3 Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
    May 23 Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
    May 9 Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update
    Apr 20 Favourable Signals For Cadrenal Therapeutics: Numerous Insiders Acquired Stock
    Apr 11 Cadrenal Therapeutics to Participate in Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18, 2024
    Apr 9 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts
    Mar 12 Cadrenal Therapeutics files for $100M mixed shelf
    See more CVKD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.13
    52 Week Low 0.36
    Average Volume 99,323
    200-Day Moving Average 0.61
    50-Day Moving Average 0.45
    20-Day Moving Average 0.47
    10-Day Moving Average 0.47
    Average True Range 0.04
    RSI (14) 49.49
    ADX 23.85
    +DI 15.68
    -DI 8.67
    Chandelier Exit (Long, 3 ATRs) 0.42
    Chandelier Exit (Short, 3 ATRs) 0.51
    Upper Bollinger Bands 0.51
    Lower Bollinger Band 0.44
    Percent B (%b) 0.39
    BandWidth 15.31
    MACD Line 0.00
    MACD Signal Line 0.00
    MACD Histogram -0.0006
    Fundamentals Value
    Market Cap 6.05 Million
    Num Shares 13 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 1.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.49
    Resistance 3 (R3) 0.50 0.49 0.49
    Resistance 2 (R2) 0.49 0.48 0.49 0.49
    Resistance 1 (R1) 0.48 0.47 0.47 0.47 0.49
    Pivot Point 0.47 0.47 0.46 0.47 0.47
    Support 1 (S1) 0.46 0.46 0.45 0.45 0.44
    Support 2 (S2) 0.45 0.45 0.45 0.44
    Support 3 (S3) 0.44 0.45 0.44
    Support 4 (S4) 0.43